Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 21, 2014; 20(15): 4453-4456
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4453
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4453
Squamous cell carcinoma after radiofrequency ablation for Barrett's dysplasia
Sebastian S Zeki, Nicholas A Wright, Stuart A McDonald, Centre for Tumour Biology, Bart’s Cancer Institute, London EC1M 6BQ, United Kingdom
Rehan Haidry, Laurence B Lovat, Research Department of General Surgery, University College London, London WC1E 6BT, United Kingdom
Manuel Justo-Rodriguez, Department of Pathology, University College London, London WC1E 6BT, United Kingdom
Author contributions: Zeki SS designed and performed research; Haidry R, Justo-Rodriguez M, Lovat LB, Wright NA and McDonald SA contributed new reagents or analytic tools; Zeki SS analyzed data and wrote the paper.
Correspondence to: Dr. Sebastian S Zeki, Centre for Tumor Biology, Bart’s Cancer Institute, Charterhouse Square, London, EC1M 6BQ, United Kingdom. sebastiz@hotmail.com
Telephone: +44-207-8827205 Fax: +44-207-8827205
Received: July 9, 2013
Revised: August 23, 2013
Accepted: September 4, 2013
Published online: April 21, 2014
Revised: August 23, 2013
Accepted: September 4, 2013
Published online: April 21, 2014
Core Tip
Core tip: The development of squamous cell cancer of the oesophagus after endoscopic ablation can happen and may add further weight to the argument for continued surveillance after radiofrequency ablation for Barrett’s related pathologies.